Inhaled Interleukin-2 in Treating Patients With Metastatic or Unresectable Cancer

Clinical trial NCT00003009 · TERMINATED

Trial details

NCT number: NCT00003009
Sponsor: University of Southern California
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Unspecified Adult Solid Tumor, Protocol Specific

Start date: 1996-02-01
Primary completion: 2000-08-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.